目的 建立急性白血?。ˋL）患者八色流式免疫表型分析起始管方案。 方法 用胞膜CD3（CD3）、CD19、CD10、CD34、CD45、胞漿CD79a（cCD79a）、髓過氧化物酶（MPO)和胞漿CD3（cCD3）等8種抗體建立八色流式染色方案。膜表面抗體直接染色；膜內(nèi)抗體經(jīng)固定破膜，再染色后上機檢測。將3個血小板減少患者骨髓標本分別進行抗體的單色染色和缺一色染色；最后對17例確診的AL初發(fā)患者標本進行檢測。 結(jié)果 用單色染色來確定染色方案中各抗體的檢測電壓及熒光補償；缺一色染色中，陽性細胞群較單色染色變化均＜10%，表明方案中的各抗體相互作用小。17例AL初發(fā)患者中，6例急性B淋巴細胞白血病原始細胞均為CD34和CD19陽性，5例cCD79a陽性和4例CD10陽性；4例急性T淋巴細胞白血病患者均為cCD3陽性；6例急性髓細胞白血病均為CD34和MPO陽性；1例B+T混合表型AL患者CD34、cCD3、CD19、cCD79a及CD10均為陽性，MPO和CD3為陰性，此檢測方案能夠確定各類AL的細胞類型。 結(jié)論 建立了AL患者八色流式免疫表型分析起始管方案，操作簡便快速，適用于臨床檢測。
引用本文： 黃巧容,余建華,蔣能剛,曾婷婷,賈永前,孟文彤. 急性白血病患者八色流式免疫表型分析起始管方案的建立. 華西醫(yī)學, 2012, 27(4): 555-559. doi: 復(fù)制
| 1. | Borowitz M, Bene MC, Harris NL, et al. Acute leukemias of ambiguous lineage[M]//Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon, IARC Press, 2008: 150-155. |
| 2. | 牛挺, 劉霆. 造血干細胞移植并發(fā)癥的防治進展[J]. 華西醫(yī)學, 2011, 26 (12): 1761-1762. |
| 3. | Brüggemann M, Schrauder A, Raff T, et al. Standardized MRD quantification in European ALL trials: proceedings of the second international symposium on MRD assessment in Kiel, Germany, 18–20 September 2008[J]. Leukemia, 2010, 24 (3): 521-535. |
| 4. | Pedreira CE, Costa ES, Barrena S, et al. Generation of flow cytometry data files with a potentially infinite number of dimensions[J]. Cytometry A, 2008, 73 (9): 834-846. |
| 5. | Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition[J]. Leukemia, 2010, 24(11): 1844-1851. |
| 6. | Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms[J]. Blood, 2008, 111(8): 3941-3967. |
| 7. | Matutes E, Pickl WF, van’t VeerM, et al. Mixed-phenotype acute leukemia: clinical and laboratory features and classification outcome in 100 patients defined according to the WHO 2008[J]. Blood, 2011, 117(11): 3163-3171. |
| 8. | van den Ancker W, Terwijn M, Westers TM, et al. Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO 2008 classification [J]. Leukemia, 2010, 24(7): 1392-1396. |
| 9. | Wood B. 9-color and 10-color flow cytometry in the clinical laboratory[J]. Arch Pathol Lab Med, 2006, 130(5): 680-690. |
| 10. | Preffer F, Dombkowski D. Advances in complex multiparameter flow cytometry technology: applications in stem cell research[J]. Cytometry B Clin Cytom, 2009, 76(5): 295-314. |
| 11. | 李麗, 付笑迎, 吳長有. 八色流式細胞術(shù)檢測人外周血BCG特異性效應(yīng)型記憶CD4~+T細胞的表型特征[J]. 細胞與分子免疫學雜志，2011, 27(5): 491-493. |
| 12. | 李麗, 付笑迎, 吳長有. 多色流式細胞術(shù)檢測人外周血BCG特異性效應(yīng)型記憶γδＴ特異性效應(yīng)型記憶[J]. 免疫學雜志, 2011, 27(5): 369-372. |
| 13. | Mahnke YD, Roederer M. Optimizing a multicolor immunophenotyping assay[J]. Clin Lab Med, 2007, 27(3): 469-487. |
| 14. | Chattopadhyay PK, Hogerkorp CM, Roederer M. A chromatic explosion: the development and future of multiparameter flow cytometry[J]. Immunology, 2008, 125(4): 441-449. |
- 1. Borowitz M, Bene MC, Harris NL, et al. Acute leukemias of ambiguous lineage[M]//Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumors: pathology and genetics of tumors of haematopoietic and lymphoid tissues. Lyon, IARC Press, 2008: 150-155.
- 2. 牛挺, 劉霆. 造血干細胞移植并發(fā)癥的防治進展[J]. 華西醫(yī)學, 2011, 26 (12): 1761-1762.
- 3. Brüggemann M, Schrauder A, Raff T, et al. Standardized MRD quantification in European ALL trials: proceedings of the second international symposium on MRD assessment in Kiel, Germany, 18–20 September 2008[J]. Leukemia, 2010, 24 (3): 521-535.
- 4. Pedreira CE, Costa ES, Barrena S, et al. Generation of flow cytometry data files with a potentially infinite number of dimensions[J]. Cytometry A, 2008, 73 (9): 834-846.
- 5. Weinberg OK, Arber DA. Mixed-phenotype acute leukemia: historical overview and a new definition[J]. Leukemia, 2010, 24(11): 1844-1851.
- 6. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms[J]. Blood, 2008, 111(8): 3941-3967.
- 7. Matutes E, Pickl WF, van’t VeerM, et al. Mixed-phenotype acute leukemia: clinical and laboratory features and classification outcome in 100 patients defined according to the WHO 2008[J]. Blood, 2011, 117(11): 3163-3171.
- 8. van den Ancker W, Terwijn M, Westers TM, et al. Acute leukemias of ambiguous lineage: diagnostic consequences of the WHO 2008 classification [J]. Leukemia, 2010, 24(7): 1392-1396.
- 9. Wood B. 9-color and 10-color flow cytometry in the clinical laboratory[J]. Arch Pathol Lab Med, 2006, 130(5): 680-690.
- 10. Preffer F, Dombkowski D. Advances in complex multiparameter flow cytometry technology: applications in stem cell research[J]. Cytometry B Clin Cytom, 2009, 76(5): 295-314.
- 11. 李麗, 付笑迎, 吳長有. 八色流式細胞術(shù)檢測人外周血BCG特異性效應(yīng)型記憶CD4~+T細胞的表型特征[J]. 細胞與分子免疫學雜志，2011, 27(5): 491-493.
- 12. 李麗, 付笑迎, 吳長有. 多色流式細胞術(shù)檢測人外周血BCG特異性效應(yīng)型記憶γδＴ特異性效應(yīng)型記憶[J]. 免疫學雜志, 2011, 27(5): 369-372.
- 13. Mahnke YD, Roederer M. Optimizing a multicolor immunophenotyping assay[J]. Clin Lab Med, 2007, 27(3): 469-487.
- 14. Chattopadhyay PK, Hogerkorp CM, Roederer M. A chromatic explosion: the development and future of multiparameter flow cytometry[J]. Immunology, 2008, 125(4): 441-449.